Torley Helen
SEC CIK 1528185 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | Pres, CEO, Dir | 787.8K | — | $83.56M | 94 | 2021-07-06 | 2026-09-09 |
Most active insiders at HALO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Torley Helen | Pres AND CEO, Dir | — | $39.85M |
| 2 | Caudill Cortney | SVP, COO | — | $2.23M |
| 3 | Posard Matthew L. | Dir | — | $2.05M |
| 4 | Connaughton Bernadette | Dir | — | $989.9K |
| 5 | Krishnan Mahesh | Dir | — | $547.8K |
| 6 | LaBrosse Nicole | SVP, CFO | — | — |
| 7 | Snyder Mark Howard | SVP, CLO | — | — |
| 8 | Appelhans Dannielle | Dir | — | — |
| 9 | Lang James Paul | Dir | — | — |
| 10 | DUNCAN BARBARA GAYLE | Dir | — | — |
Transactions 94
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-11 20:35 | 2026-09-09+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $18.41 | +60.0K | 787.8K | +8% | +$1.10M |
| DMT | 2026-09-11 20:35 | 2026-09-09+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $107.28 | -60.0K | 767.8K | -7% | -$6.44M |
| DMT | 2026-08-19 20:01 | 2026-08-17+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $18.41 | +60.0K | 787.8K | +8% | +$1.10M |
| DMT | 2026-08-19 20:01 | 2026-08-17+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $104.59 | -60.0K | 767.8K | -7% | -$6.28M |
| DT | 2026-07-09 17:19 | 2026-07-08 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $12.07 | +1,923 | 769.7K | +0.3% | +$23.2K |
| DMT | 2026-07-09 17:19 | 2026-07-08 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $79.77 | -1,923 | 767.8K | -0.2% | -$153.4K |
| DMT | 2026-06-03 20:06 | 2026-06-01+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $12.07 | +50.0K | 777.8K | +7% | +$603.5K |
| DMT | 2026-06-03 20:06 | 2026-06-01+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $67.40 | -50.0K | 767.8K | -6% | -$3.37M |
| DMT | 2026-05-13 17:50 | 2026-05-11+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $12.07 | +50.0K | 777.8K | +7% | +$603.5K |
| DMT | 2026-05-13 17:50 | 2026-05-11+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $68.68 | -50.0K | 767.8K | -6% | -$3.43M |
| DT | 2026-04-07 17:13 | 2026-04-06 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $12.07 | +10.0K | 777.8K | +1% | +$120.7K |
| DMT | 2026-04-07 17:13 | 2026-04-06 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $63.50 | -10.0K | 767.8K | -1% | -$635.0K |
| DMT | 2026-04-02 18:28 | 2026-04-01+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $12.07 | +40.0K | 787.8K | +5% | +$482.8K |
| DMT | 2026-04-02 18:28 | 2026-04-01+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $64.81 | -40.0K | 767.8K | -5% | -$2.59M |
| DM | 2026-03-04 | 2026-03-02+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $69.52 | -50.0K | 767.8K | -6% | -$3.48M |
| DM | 2026-03-04 | 2026-03-02+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $12.07 | +50.0K | 787.8K | +7% | +$603.5K |
| DM | 2026-02-24 | 2026-02-20+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +39.2K | 779.9K | +5% | $0 |
| DM | 2026-02-24 | 2026-02-20+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | F - Tax | $70.79 | -21.1K | 767.8K | -3% | -$1.50M |
| DM | 2026-02-17 | 2026-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | F - Tax | $79.44 | -48.0K | 726.2K | -6% | -$3.82M |
| DM | 2026-02-17 | 2026-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +89.1K | 735.3K | +14% | $0 |
| DM | 2026-02-05 | 2026-02-03+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $77.07 | -50.0K | 708.7K | -7% | -$3.85M |
| DM | 2026-02-05 | 2026-02-03+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $12.07 | +50.0K | 728.7K | +7% | +$603.5K |
| DM | 2025-12-01 | 2025-12-01 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $68.92 | -16.6K | 709.0K | -2% | -$1.14M |
| D | 2025-12-01 | 2025-11-26 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | G - Gift | $0.00 | -25.0K | 708.7K | -3% | $0 |
| D | 2025-12-01 | 2025-12-01 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $8.11 | +16.6K | 725.3K | +2% | +$134.4K |
| DM | 2025-11-12 | 2025-11-10+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $69.46 | -60.0K | 733.8K | -8% | -$4.17M |
| DM | 2025-11-12 | 2025-11-10+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $8.11 | +60.0K | 753.7K | +9% | +$486.6K |
| DM | 2025-10-03 | 2025-10-01+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $71.86 | -60.0K | 737.1K | -8% | -$4.31M |
| DM | 2025-10-03 | 2025-10-01+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $8.11 | +60.0K | 753.7K | +9% | +$486.6K |
| DM | 2025-09-04 | 2025-09-02+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $8.11 | +60.0K | 753.7K | +9% | +$486.6K |
| DM | 2025-09-04 | 2025-09-02+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $74.08 | -60.0K | 744.2K | -7% | -$4.44M |
| DM | 2025-08-13 | 2025-08-11+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $63.62 | -60.0K | 735.0K | -8% | -$3.82M |
| DM | 2025-08-13 | 2025-08-11+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $8.11 | +60.0K | 753.7K | +9% | +$486.6K |
| DM | 2025-07-10 | 2025-07-08+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $56.46 | -60.0K | 733.9K | -8% | -$3.39M |
| DM | 2025-07-10 | 2025-07-08+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $8.11 | +60.0K | 753.7K | +9% | +$486.6K |
| DM | 2025-06-24 | 2025-06-20+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $8.11 | +60.0K | 753.7K | +9% | +$486.6K |
| DM | 2025-06-24 | 2025-06-20+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $53.09 | -60.0K | 733.7K | -8% | -$3.19M |
| D | 2025-02-24 | 2025-02-23 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | F - Tax | $57.75 | -12.1K | 733.7K | -2% | -$697.7K |
| D | 2025-02-24 | 2025-02-23 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +22.4K | 745.8K | +3% | $0 |
| DM | 2025-02-18 | 2025-02-15+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +122.8K | 744.5K | +20% | $0 |
| DM | 2025-02-18 | 2025-02-15+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | F - Tax | $58.29 | -66.2K | 705.9K | -9% | -$3.86M |
| 2024-12-03 | 2024-11-29 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | G - Gift | $0.00 | -10.0K | 666.7K | -1% | $0 | |
| DM | 2024-10-09 | 2024-10-08+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $13.87 | +20.0K | 686.7K | +3% | +$277.4K |
| DM | 2024-10-09 | 2024-10-08+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $53.29 | -20.0K | 680.8K | -3% | -$1.07M |
| DM | 2024-09-26 | 2024-09-24+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $13.87 | +30.0K | 686.7K | +5% | +$416.1K |
| DM | 2024-09-26 | 2024-09-24+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $56.88 | -30.0K | 676.7K | -4% | -$1.71M |
| DM | 2024-09-12 | 2024-09-10+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $13.87 | +30.0K | 686.7K | +5% | +$416.1K |
| DM | 2024-09-12 | 2024-09-10+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $59.13 | -30.0K | 676.7K | -4% | -$1.77M |
| DM | 2024-08-15 | 2024-08-13+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $57.15 | -30.0K | 676.7K | -4% | -$1.71M |
| DM | 2024-08-15 | 2024-08-13+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $13.87 | +30.0K | 686.7K | +5% | +$416.1K |
| DM | 2024-02-20 | 2024-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +37.9K | 680.2K | +6% | $0 |
| DM | 2024-02-20 | 2024-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | F - Tax | $36.10 | -20.4K | 676.7K | -3% | -$735.1K |
| D | 2024-02-16 | 2024-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | A - Grant | $0.00 | +32.8K | 676.8K | +5% | $0 |
| DM | 2024-02-16 | 2024-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | F - Tax | $35.91 | -24.7K | 644.1K | -4% | -$885.4K |
| D | 2024-02-16 | 2024-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +13.1K | 651.1K | +2% | $0 |
| D | 2024-02-13 | 2024-02-10 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +31.3K | 654.9K | +5% | $0 |
| D | 2024-02-13 | 2024-02-10 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | F - Tax | $35.49 | -16.9K | 638.0K | -3% | -$601.3K |
| DM | 2023-08-31 | 2023-08-29+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $13.87 | +30.0K | 633.7K | +5% | +$416.1K |
| DM | 2023-08-31 | 2023-08-29+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $42.69 | -30.0K | 623.7K | -5% | -$1.28M |
| DM | 2023-08-17 | 2023-08-15+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $13.87 | +30.0K | 633.7K | +5% | +$416.1K |
| DM | 2023-08-17 | 2023-08-15+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $43.49 | -30.0K | 623.7K | -5% | -$1.30M |
| DM | 2023-07-27 | 2023-07-25+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $13.87 | +30.0K | 633.7K | +5% | +$416.1K |
| DM | 2023-07-27 | 2023-07-25+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $43.09 | -30.0K | 623.7K | -5% | -$1.29M |
| DM | 2023-03-09 | 2023-03-07+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $14.66 | +30.0K | 633.7K | +5% | +$439.8K |
| DM | 2023-03-09 | 2023-03-07+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $43.82 | -30.0K | 623.7K | -5% | -$1.31M |
| 2023-03-01 | 2023-03-01 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | G - Gift | $0.00 | -10.0K | 623.7K | -2% | $0 | |
| D | 2023-02-21 | 2023-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $49.26 | -11.1K | 633.7K | -2% | -$544.9K |
| D | 2023-02-21 | 2023-02-16 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +21.0K | 644.7K | +3% | $0 |
| D | 2023-02-17 | 2023-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +13.1K | 630.6K | +2% | $0 |
| D | 2023-02-17 | 2023-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | F - Tax | $49.20 | -6,892 | 623.7K | -1% | -$339.1K |
| DM | 2023-02-14 | 2023-02-10+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $0.00 | +64.1K | 634.8K | +11% | $0 |
| DM | 2023-02-14 | 2023-02-10+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | F - Tax | $48.92 | -33.7K | 602.0K | -5% | -$1.65M |
| DM | 2023-02-09 | 2023-02-07+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $14.66 | +30.0K | 597.2K | +5% | +$439.8K |
| DM | 2023-02-09 | 2023-02-07+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $51.01 | -30.0K | 587.2K | -5% | -$1.53M |
| DM | 2023-01-19 | 2023-01-17+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $51.31 | -30.0K | 588.3K | -5% | -$1.54M |
| DM | 2023-01-19 | 2023-01-17+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $14.66 | +30.0K | 597.2K | +5% | +$439.8K |
| DM | 2022-12-15 | 2022-12-13+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $58.11 | -30.0K | 587.7K | -5% | -$1.74M |
| DM | 2022-12-15 | 2022-12-13+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $14.66 | +30.0K | 597.2K | +5% | +$439.8K |
| DM | 2022-11-17 | 2022-11-15+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | S - Sale+OE | $53.39 | -30.0K | 587.2K | -5% | -$1.60M |
| DM | 2022-11-17 | 2022-11-15+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres AND CEO, Dir | M - OptEx | $14.66 | +30.0K | 597.2K | +5% | +$439.8K |
| D | 2022-02-17 | 2022-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | F - Tax | $34.43 | -6,892 | 587.2K | -1% | -$237.3K |
| D | 2022-02-17 | 2022-02-15 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | M - OptEx | $0.00 | +13.1K | 594.1K | +2% | $0 |
| DM | 2022-02-14 | 2022-02-10+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | F - Tax | $34.28 | -49.0K | 567.4K | -8% | -$1.68M |
| DM | 2022-02-14 | 2022-02-10+ | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | M - OptEx | $0.00 | +92.8K | 584.6K | +19% | $0 |
| D | 2021-11-08 | 2021-11-08 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | M - OptEx | $14.66 | +50.0K | 587.2K | +9% | +$733.0K |
| DM | 2021-11-08 | 2021-11-08 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | S - Sale+OE | $39.82 | -50.0K | 549.4K | -8% | -$1.99M |
| DM | 2021-10-04 | 2021-10-04 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | S - Sale+OE | $40.08 | -50.0K | 543.0K | -8% | -$2.00M |
| D | 2021-10-04 | 2021-10-04 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | M - OptEx | $14.66 | +50.0K | 587.2K | +9% | +$733.0K |
| DM | 2021-09-07 | 2021-09-07 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | S - Sale+OE | $42.38 | -50.0K | 543.7K | -8% | -$2.12M |
| D | 2021-09-07 | 2021-09-07 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | M - OptEx | $14.66 | +50.0K | 587.2K | +9% | +$733.0K |
| DM | 2021-08-10 | 2021-08-10 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | S - Sale+OE | $41.11 | -50.0K | 539.1K | -8% | -$2.06M |
| D | 2021-08-10 | 2021-08-10 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | M - OptEx | $14.66 | +50.0K | 587.2K | +9% | +$733.0K |
| D | 2021-07-06 | 2021-07-06 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | M - OptEx | $14.66 | +50.0K | 587.2K | +9% | +$733.0K |
| D | 2021-07-06 | 2021-07-06 | HALO | HALOZYME THERAPEUTICS, INC. | Torley Helen | Pres, CEO, Dir | S - Sale+OE | $45.97 | -50.0K | 537.2K | -9% | -$2.30M |
Purchase Sale Sale after option exercise All abbreviations